pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells.
暂无分享,去创建一个
Richard J. Lee | J. Brugge | G. Inghirami | C. Albanese | W. Muller | R. Davis | R. Pestell | G. Watanabe | G. K. Haines | M. Webster | R. J. Lee | C. Albanese | R. J. Stenger | Robert J. Stenger
[1] J. Yasuda,et al. A mammalian scaffold complex that selectively mediates MAP kinase activation. , 1998, Science.
[2] M. Greenberg,et al. Fos Family Members Induce Cell Cycle Entry by Activating Cyclin D1 , 1998, Molecular and Cellular Biology.
[3] R. Tennant,et al. Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo. , 1998, Genes & development.
[4] D. Alessi,et al. Mitogen‐ and stress‐activated protein kinase‐1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB , 1998, The EMBO journal.
[5] Richard J. Lee,et al. Transforming Potential of Dbl Family Proteins Correlates with Transcription from the Cyclin D1 Promoter but Not with Activation of Jun NH2-terminal Kinase, p38/Mpk2, Serum Response Factor, or c-Jun* , 1998, The Journal of Biological Chemistry.
[6] R. Pestell,et al. Regulation of cyclin dependent kinase inhibitor proteins during neonatal cerebella development. , 1998, Brain research. Developmental brain research.
[7] R. Pestell,et al. Catalytic activation of extracellular signal-regulated kinases induces cyclin D1 expression in primary tracheal myocytes. , 1998, American journal of respiratory cell and molecular biology.
[8] J. Darnell,et al. Stat3 Activation Is Required for Cellular Transformation by v-src , 1998, Molecular and Cellular Biology.
[9] D. Johnson,et al. Expression of the v-Src oncoprotein in fibroblasts disrupts normal regulation of the CDK inhibitor p27 and inhibits quiescence , 1998, Oncogene.
[10] P. Leder,et al. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes , 1998, Oncogene.
[11] V. Fried,et al. c-Jun NH2-terminal Kinases Target the Ubiquitination of Their Associated Transcription Factors* , 1997, The Journal of Biological Chemistry.
[12] P. Rakic,et al. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene , 1997, Nature.
[13] R. Tjian,et al. TAFII250-dependent transcription of cyclin A is directed by ATF activator proteins. , 1997, Genes & development.
[14] P. Cohen,et al. The search for physiological substrates of MAP and SAP kinases in mammalian cells. , 1997, Trends in cell biology.
[15] M E Greenberg,et al. A cytoplasmic inhibitor of the JNK signal transduction pathway. , 1997, Science.
[16] R. Weinberg,et al. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution , 1997, Molecular and cellular biology.
[17] F. Zindy,et al. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. , 1997, Genes & development.
[18] J. LaBaer,et al. New functional activities for the p21 family of CDK inhibitors. , 1997, Genes & development.
[19] M. Ewen,et al. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein , 1997, Nature.
[20] M. Gaestel,et al. CREB is activated by UVC through a p38/HOG‐1‐dependent protein kinase , 1997, The EMBO journal.
[21] C. Der,et al. Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways , 1997, Molecular and cellular biology.
[22] J. Massagué,et al. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. , 1997, Genes & development.
[23] J. Blenis,et al. Neurotransmitter- and Growth Factor-Induced cAMP Response Element Binding Protein Phosphorylation in Glial Cell Progenitors: Role of Calcium Ions, Protein Kinase C, and Mitogen-Activated Protein Kinase/Ribosomal S6 Kinase Pathway , 1997, The Journal of Neuroscience.
[24] Philip R. Cohen,et al. Activation of stress‐activated protein kinase‐3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38) , 1997, The EMBO journal.
[25] J. Bartek,et al. Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint , 1996, Molecular and cellular biology.
[26] L. Zon,et al. Induction of cyclin D1 by simian virus 40 small tumor antigen. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[27] R. Davis,et al. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways , 1996, Journal of Molecular Medicine.
[28] Richard J. Lee,et al. Angiotensin II Activation of Cyclin D1-dependent Kinase Activity* , 1996, The Journal of Biological Chemistry.
[29] Richard J. Lee,et al. Reduced Cyclin D1 Expression in the Cerebella of Nutritionally Deprived Rats Correlates with Developmental Delay and Decreased Cellular DNA Synthesis , 1996, Journal of neuropathology and experimental neurology.
[30] Philip R. Cohen,et al. FGF and stress regulate CREB and ATF‐1 via a pathway involving p38 MAP kinase and MAPKAP kinase‐2. , 1996, The EMBO journal.
[31] J. Pouysségur,et al. Cyclin D1 Expression Is Regulated Positively by the p42/p44MAPK and Negatively by the p38/HOGMAPK Pathway* , 1996, The Journal of Biological Chemistry.
[32] A. Sabichi,et al. Dominant-negative mutants of cJun inhibit AP-1 activity through multiple mechanisms and with different potencies. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[33] Bart,et al. Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit , 1996, Molecular and cellular biology.
[34] R. Davis,et al. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway , 1996, Molecular and cellular biology.
[35] P. Brown,et al. Activation and inhibition of the AP‐1 complex in human breast cancer cells , 1996, Molecular carcinogenesis.
[36] M. Merino,et al. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions , 1995, Nature Medicine.
[37] Michael E. Greenberg,et al. Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.
[38] Philip R. Cohen,et al. PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*) , 1995, The Journal of Biological Chemistry.
[39] H. Herschman,et al. v-src Induces Prostaglandin Synthase 2 Gene Expression by Activation of the c-Jun N-terminal Kinase and the c-Jun Transcription Factor (*) , 1995, The Journal of Biological Chemistry.
[40] C. Albanese,et al. Transforming p21ras Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions (*) , 1995, The Journal of Biological Chemistry.
[41] R. Cardiff,et al. Induction of mammary epithelial hyperplasias and mammary tumors in transgenic mice expressing a murine mammary tumor virus/activated c-src fusion gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[42] M. Karin. The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases (*) , 1995, The Journal of Biological Chemistry.
[43] S. Ng,et al. Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells , 1995, Molecular and cellular biology.
[44] M. Karin,et al. Selective activation of the JNK signaling cascadeand c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs , 1995, Cell.
[45] E. Goldsmith,et al. How MAP Kinases Are Regulated (*) , 1995, The Journal of Biological Chemistry.
[46] D. Mukhopadhyay,et al. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation , 1995, Nature.
[47] J. Bartek,et al. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 , 1995, Nature.
[48] Philip R. Cohen,et al. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1 , 1995, FEBS letters.
[49] R. Weinberg,et al. The retinoblastoma protein and cell cycle control , 1995, Cell.
[50] M E Greenberg,et al. Calcium signaling in neurons: molecular mechanisms and cellular consequences. , 1995, Science.
[51] C. Downes,et al. Cooperation of Src Homology Domains in the Regulated Binding of Phosphatidylinositol 3-Kinase , 1995, The Journal of Biological Chemistry.
[52] N. Jones,et al. ATF‐2 contains a phosphorylation‐dependent transcriptional activation domain. , 1995, The EMBO journal.
[53] B. Dérijard,et al. Transcription factor ATF2 regulation by the JNK signal transduction pathway , 1995, Science.
[54] C. Albanese,et al. c-Jun represses transcription of the human chorionic gonadotropin alpha and beta genes through distinct types of CREs. , 1994, The Journal of biological chemistry.
[55] T. Hunter,et al. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age , 1994, Cell.
[56] C. Sherr. G1 phase progression: Cycling on cue , 1994, Cell.
[57] J. Maller,et al. Regulation of mitogen-activated protein kinase activation by protein kinases A and C in a cell-free system. , 1994, The Journal of biological chemistry.
[58] H. Herschman,et al. v-src induction of the TIS10/PGS2 prostaglandin synthase gene is mediated by an ATF/CRE transcription response element , 1994, Molecular and cellular biology.
[59] R. Sutherland,et al. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[60] Emma Lees,et al. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice , 1994, Nature.
[61] Jiri Bartek,et al. Cyclin D1 protein expression and function in human breast cancer , 1994, International journal of cancer.
[62] J.M. Adams,et al. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. , 1994, The EMBO journal.
[63] M. Skolnick,et al. A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.
[64] H. Sato,et al. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. , 1993, The Journal of biological chemistry.
[65] J. A. Hamilton,et al. Expression and amplification of cyclin genes in human breast cancer. , 1993, Oncogene.
[66] J. A. Hamilton,et al. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. , 1993, Molecular and cellular biology.
[67] G. Staal,et al. Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. , 1992, Cancer research.
[68] R. Jove,et al. Regulation of the junB gene by v-src , 1992, Molecular and cellular biology.
[69] P. Bédard,et al. Transcriptional activation of the CEF-4/9E3 cytokine gene by pp60v-src , 1992, Molecular and cellular biology.
[70] E. Schuuring,et al. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. , 1992, Oncogene.
[71] E. Kandel,et al. Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors , 1991, Nature.
[72] G. Waeber,et al. Developmental stage-specific expression of cyclic adenosine 3',5'-monophosphate response element-binding protein CREB during spermatogenesis involves alternative exon splicing. , 1991, Molecular endocrinology.
[73] V. Sukhatme,et al. v-Src activates mitogen-responsive transcription factor Egr-1 via serum response elements. , 1991, The Journal of biological chemistry.
[74] M. Greenberg,et al. CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. , 1991, Science.
[75] M. Sporn,et al. Transcriptional regulation of the transforming growth factor beta 1 promoter by v-src gene products is mediated through the AP-1 complex , 1990, Molecular and cellular biology.
[76] B. Wasylyk,et al. The collagenase gene promoter contains a TPA and oncogene‐responsive unit encompassing the PEA3 and AP‐1 binding sites. , 1990, The EMBO journal.
[77] M. Montminy,et al. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133 , 1989, Cell.
[78] M. Shibuya,et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. , 1987, The Journal of biological chemistry.
[79] H. Temin,et al. Overexpressed pp60c-src can induce focus formation without complete transformation of NIH 3T3 cells , 1985, Molecular and cellular biology.
[80] R. Erikson,et al. Avian sarcoma virus-transforming protein, pp60src shows protein kinase activity specific for tyrosine , 1980, Nature.
[81] Sheila M. Thomas,et al. Cellular functions regulated by Src family kinases. , 1997, Annual review of cell and developmental biology.
[82] Y. Uehara,et al. Use and selectivity of herbimycin A as inhibitor of protein-tyrosine kinases. , 1991, Methods in enzymology.
[83] H. Hanafusa. Cell Transformation by RNA Tumor Viruses , 1977 .